Rigel Pharmaceuticals | RIGL - إيرادات الفوائد





إيرادات الفوائد تغيير تاريخ
Arrowhead Research USD 9.69M 637K 2025-12
AstraZeneca USD 73M 62M 2026-03
BioMarin Pharmaceutical USD 22.56M 3.35M 2026-03
Daiichi Sankyo JPY 9.96B 230M 2024-03
Eli Lilly USD 65M 25M 2025-09
Heron Therapeutics USD 433K 277K 2021-12
Intrexon USD 319K 602K 2024-06
Ionis Pharmaceuticals USD -0.66 0.29 2024-12
Karyopharm Therapeutics USD -0.15 0.11 2024-12
Ligand Pharmaceuticals USD 6.39M 2.52M 2025-12
MacroGenics USD 1.53M 114K 2025-09
Pfizer USD 115M 51M 2026-03
Regeneron Pharmaceuticals USD 193.3M 18.2M 2025-12
Rigel Pharmaceuticals USD 0.7 0.76 2024-09
Ultragenyx Pharmaceutical USD 6.51M 649K 2025-12
Veracyte USD 3.48M 545K 2025-09